D'Amico F, Fanizzi F, Dal Buono A, Gabbiadini R, et al. Effectiveness and safety of mirikizumab in patients with moderate-to-severe ulcerative colitis: the miri real multicenter study. J Crohns Colitis 2026;20:jjag062.
PMID: 42252131